Black Diamond Therapeutic Q3 EPS $(0.45) Beats $(0.46) Estimate; Cash, Cash Equivalents, And Investments Of $144.3M, Expected To Be Sufficient To Fund Operations Into 1H Of 2025
Black Diamond Therapeutic Q3 EPS $(0.45) Beats $(0.46) Estimate; Cash, Cash Equivalents, And Investments Of $144.3M, Expected To Be Sufficient To Fund Operations Into 1H Of 2025
黑钻治疗第三季度每股收益为0.45美元，超过了美元（0.46）的预期；现金、现金等价物和投资为1.443亿美元，预计足以为2025年上半年的运营提供资金
Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.46) by 2.17 percent. This is a 25 percent increase over losses of $(0.60) per share from the same period last year.
黑钻疗法（纳斯达克股票代码：BDTX）公布季度每股亏损0.45美元，比分析师普遍估计的0.46美元（0.46美元）高出2.17％。这比去年同期每股亏损美元（0.60美元）增加了25％。